Flotek Industries Inc FTK
We take great care to ensure that the data presented and summarized in this overview for FLOTEK INDUSTRIES INC is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in FTK
Top Purchases
Top Sells
About FTK
Flotek Industries, Inc. operates as a technology-driven chemistry and data company that serves customers across industrial, commercial, and consumer markets in the United States, the United Arab Emirates, and internationally. It operates in two segments, Chemistry Technologies (CT) and Data Analytics (DA). The CT segment designs, develops, manufactures, packages, distributes, delivers, and markets green specialty chemicals that enhance the profitability of hydrocarbon producers and cleans surfaces in commercial and personal settings to help reduce the spread of bacteria, viruses, and germs. This segment primarily serves integrated oil and gas, oilfield services, independent oil and gas, national and state-owned oil, geothermal energy, solar energy, and alternative energy companies. The DA segment designs, develops, produces, sells, and supports equipment and services that create and provide valuable information on the composition and properties of energy customers' hydrocarbon fluids. This segment's data platforms combine the energy industry's field-deployable, inline optical analyzer with proprietary cloud visualization and analytics. It sells its products directly through a mix of in-house sales professionals, as well as contractual agency agreements. The company was incorporated in 1985 and is headquartered in Houston, Texas.
Insider Transactions at FTK
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 05
2024
|
Harshavardhan V Agadi Director |
BUY
Grant, award, or other acquisition
|
Direct |
22,173
+7.92%
|
-
|
Jun 05
2024
|
Evan R Farber Director |
BUY
Grant, award, or other acquisition
|
Direct |
22,173
+28.92%
|
-
|
Jun 05
2024
|
Lisa Mayr Director |
BUY
Grant, award, or other acquisition
|
Direct |
22,173
+24.97%
|
-
|
Jun 05
2024
|
Michael Fucci Director |
BUY
Grant, award, or other acquisition
|
Direct |
22,173
+22.41%
|
-
|
Apr 19
2024
|
Ryan Gillis Ezell CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,973
-1.89%
|
$5,919
$3.46 P/Share
|
Mar 08
2024
|
Ryan Gillis Ezell CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,429
-1.35%
|
$2,858
$2.79 P/Share
|
Dec 29
2023
|
Ryan Gillis Ezell CEO |
BUY
Grant, award, or other acquisition
|
Direct |
2,223
+2.06%
|
$6,669
$3.33 P/Share
|
Dec 19
2023
|
James Bond Clement Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,627
-3.86%
|
$16,881
$3.83 P/Share
|
Dec 14
2023
|
David Nierenberg Director |
BUY
Open market or private purchase
|
Indirect |
19,481
+1.54%
|
$58,443
$3.72 P/Share
|
Dec 13
2023
|
David Nierenberg Director |
BUY
Open market or private purchase
|
Indirect |
33,118
+2.63%
|
$99,354
$3.53 P/Share
|
Dec 12
2023
|
David Nierenberg Director |
BUY
Open market or private purchase
|
Indirect |
12,735
+1.32%
|
$38,205
$3.42 P/Share
|
Dec 11
2023
|
David Nierenberg Director |
BUY
Open market or private purchase
|
Indirect |
9,006
+4.48%
|
$27,018
$3.19 P/Share
|
Dec 05
2023
|
Ryan Gillis Ezell CEO |
BUY
Grant, award, or other acquisition
|
Direct |
13,974
+11.77%
|
-
|
Dec 05
2023
|
James Bond Clement Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,163
+12.03%
|
-
|
Nov 27
2023
|
Ryan Gillis Ezell CEO |
BUY
Open market or private purchase
|
Direct |
6,225
+3.37%
|
$18,675
$4.0 P/Share
|
Nov 17
2023
|
Michael Fucci Director |
BUY
Open market or private purchase
|
Direct |
7,693
+6.21%
|
$23,079
$3.9 P/Share
|
Nov 14
2023
|
James Bond Clement Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
5,030
+7.27%
|
$15,090
$3.98 P/Share
|
Jul 19
2023
|
Harshavardhan V Agadi Director |
BUY
Grant, award, or other acquisition
|
Direct |
150,000
+9.59%
|
-
|
Jul 01
2023
|
Harshavardhan V Agadi Director |
BUY
Grant, award, or other acquisition
|
Direct |
136,986
+9.78%
|
-
|
Jul 01
2023
|
David Nierenberg Director |
BUY
Grant, award, or other acquisition
|
Direct |
241,096
+36.49%
|
-
|
Last 12 Months Summary
Grant, award, or other acquisition | 115K shares |
---|---|
Open market or private purchase | 93.3K shares |
Payment of exercise price or tax liability | 9.03K shares |
---|